@inproceedings{inproceedings, title  = {{Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase III ECZTRA 6 trial}},

 url = {{}},

 year = {{2022}},

 month = {{1}},

 author = {{Paller A and Blauvelt A and Soong W and Imafuku S and Hong C and Schuttelaar MLA and Amoudruz P and Kurbasic A and Soldbro L and Lophaven K and Schneider S et al}},

 volume = {{186}},

 journal = {{BRITISH JOURNAL OF DERMATOLOGY}},

 issue = {{4}},

 pages = {{E145-E146}},

 note = {{Accessed on 2024/12/22}}}